SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008712
Filing Date
2017-08-09
Accepted
2017-08-09 09:01:37
Documents
64
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 435754
2 ex31-1.htm EX-31.1 19717
3 ex31-2.htm EX-31.2 12724
4 ex32-1.htm EX-32.1 7390
5 ex32-2.htm EX-32.2 7397
  Complete submission text file 0001493152-17-008712.txt   2936527

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE crbp-20170630.xml EX-101.INS 408547
7 XBRL SCHEMA FILE crbp-20170630.xsd EX-101.SCH 39359
8 XBRL CALCULATION FILE crbp-20170630_cal.xml EX-101.CAL 59684
9 XBRL DEFINITION FILE crbp-20170630_def.xml EX-101.DEF 132981
10 XBRL LABEL FILE crbp-20170630_lab.xml EX-101.LAB 292438
11 XBRL PRESENTATION FILE crbp-20170630_pre.xml EX-101.PRE 224462
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 171016578
SIC: 2834 Pharmaceutical Preparations